EU phê duyệt vaccine đặc biệt đối phó các biến thể phụ của Omicron
Ngày 12/9, Cơ quan giám sát dược phẩm của Liên minh châu Âu (EU) đã phê duyệt một loại vaccine đặc biệt nhằm vào các biến thể phụ mới và có khả năng lây nhiễm cao của Omicron trong bối cảnh xuất hiện lo ngại về làn sóng lây nhiễm COVID-19 trong mùa Đông này.
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
(Vietnam+)